Haurwitz Rachel E. 4
4 · Caribou Biosciences, Inc. · Filed Feb 23, 2023
Insider Transaction Report
Form 4
Haurwitz Rachel E.
DirectorPresident and CEO
Transactions
- Award
Option to purchase Common Stock
2023-02-21+510,500→ 510,500 totalExercise: $6.12Exp: 2033-02-20→ Common Stock (510,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.